With years of experience in pathology and genetic discovery research, we can help get you from bench to bedside with your research.
We have a variety of resources we can apply to tumor model evaluation including:
We perform a standardized assessment of disease severity for models of musculary dystrophy comparing customer samples to an mdx control set. Using immunohistochemistry for embryonic myosin heavy chain (regenerating fibers) and IgM (degenerating fibers), central nuclei and macrophage counts are quantified using digital imaging analysis (Hamamatsu software). Raw data with or without subsequent comparisons to control datasets can be provided along with digital images of stained muscle.
We like to have a phone discussion to fully understand your needs before preparing a quote for services. Contact us to discuss your project.